van den BergheG, WoutersP, WeekersF, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med, 2001; 345:359–1367.
2.
Van den BergheG, WilmerA, HermansG, et al.: Intensive insulin therapy in the medical ICU. N Engl J Med, 2006; 354:449–461.
3.
SiegelaarSE, BarwariT, HermanidesJ, et al.: Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J Thorac Cardiovasc Surg, 2013; 146:1283–1289.
4.
GandhiGY, NuttallGA, AbelMD, et al.: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med, 2007; 146:233–243.
5.
SchusterKM, BarreK, InzucchiSE, et al.: Continuous glucose monitoring in the surgical intensive care unit: concordance with capillary glucose. J Trauma Acute Care Surg, 2014; 76:798–803.
6.
ForlenzaGP, NathanBM, MoranA, et al.: Accuracy of continuous glucose monitoring in patients after total pancreatectomy with islet autotransplantation. Diabetes Technol Ther, 2016; 18:455–463.
7.
BellinMD, GelrudA, Arreaza-RubinG, et al.: Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop. Pancreas, 2014; 43:1163–1171.
8.
BellinMD, BeilmanGJ, DunnTB, et al.: Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy. Pancreas, 2013; 42:317–321.
9.
ForlenzaGP, NathanBM, MoranAM, et al.: Successful application of closed-loop artificial pancreas therapy after islet autotransplantation. Am J Transplant, 2016; 16:527–534.
10.
RuizJL, SherrJL, CengizE, et al.: Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol, 2012; 6:1123–1130.
11.
ClarkeWL, CoxD, Gonder-FrederickLA, et al.: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care, 1987; 10:622–628.
12.
ClarkeWL.: The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther, 2005; 7:776–779.
13.
KovatchevBP, WakemanCA, BretonMD, et al.: Computing the surveillance error grid analysis: procedure and examples. J Diabetes Sci Technol, 2014; 8:673–684.
14.
KlonoffDC, LiasC, VigerskyR, et al.: The surveillance error grid. J Diabetes Sci Technol, 2014; 8:658–672.
15.
BodeBW, GrossTM, ThorntonKR, et al.: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract, 1999; 46:183–190.
16.
BasuA, DubeS, SlamaM, et al.: Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes, 2013. 62:4083–4087.
17.
De BlockCE, GiosJ, VerheyenN, et al.: Randomized evaluation of glycemic control in the medical intensive care unit using real-time continuous glucose monitoring (REGIMEN Trial). Diabetes Technol Ther, 2015; 17:889–898.
18.
FinziG., DavalliA, PlacidiC, et al.: Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol, 2005; 29:525–533.
19.
NacherV, MerinoJF, RaurellM, et al.: Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. Diabetes, 1998; 47:192–196.
